{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:12:21Z","timestamp":1785769941261,"version":"3.56.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Neonatal abstinence syndrome is an array of signs and symptoms experienced by a newborn due to abrupt discontinuation of intrauterine exposure to certain drugs, primarily opioids. In the United States, the incidence of neonatal abstinence syndrome has tripled over the past decade. The current standard of care for drug testing includes the analysis of infant urine and meconium. Sample collection is associated with several limitations, including diaper media interferences, limited sample amount, sample heterogeneity, and the need for professional staff for collection. Umbilical cord tissue has emerged as a convenient sample matrix for testing owing to its universal availability. The purpose of this study was to examine umbilical cords using an untargeted metabolomics approach to determine the detected drugs and validate an analytical method to confirm and quantify the identified drugs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A metabolomics analysis was performed with 21 umbilical cords to screen for drugs and drug metabolites by liquid chromatography\u2013mass spectrometry. Drugs were identified using the National Institute of Standards and Technology database, and an analytical method was developed and validated using secondary liquid chromatography\u2013mass spectrometry instrument for positive confirmation and quantitative analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Twenty-one random umbilical cords from women were tested: 4 were positive for cocaine and the primary and secondary metabolites; one was positive for methadone, the primary metabolite; 3 were positive for cotinine, the metabolite of nicotine; and 5 were positive for acetyl norfentanyl.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Our research is a prospective method development study using untargeted and targeted approaches to characterize steady-state drug metabolite levels in the umbilical cord matrix at the time of delivery. By characterizing drug type and concentration, this methodology can be used to develop a reliable complementary testing method for meconium toxicology screens.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ftd.0000000000000753","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T07:45:39Z","timestamp":1583480739000},"page":"787-794","source":"Crossref","is-referenced-by-count":4,"title":["Screening for Opioid and Stimulant Exposure In Utero Through Targeted and Untargeted Metabolomics Analysis of Umbilical Cords"],"prefix":"10.1097","volume":"42","author":[{"given":"Srivalli Swathi","family":"Mamillapalli","sequence":"first","affiliation":[{"name":"Department of Chemistry, Thomas Harriot College of Arts and Sciences, East Carolina University;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Smith-Joyner","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Thomas Harriot College of Arts and Sciences, East Carolina University;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Forbes","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Brody School of Medicine at East Carolina University;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadesha","family":"McIntyre","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Brody School of Medicine, East Carolina University;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Poppenfuse","sequence":"additional","affiliation":[{"name":"Department of Biology, East Carolina University;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blake","family":"Rushing","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cody","family":"Strom","sequence":"additional","affiliation":[{"name":"Department of Kinesiology, College of Health and Human Performance, East Carolina University; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison S.","family":"Danell","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Thomas Harriot College of Arts and Sciences, East Carolina University;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"May","sequence":"additional","affiliation":[{"name":"Department of Kinesiology, College of Health and Human Performance, East Carolina University; and"},{"name":"ECU Medical & Health Sciences Foundation, School of Dental Medicine, East Carolina University, Greenville, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devon","family":"Kuehn","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Brody School of Medicine at East Carolina University;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Kew","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Thomas Harriot College of Arts and Sciences, East Carolina University;"},{"name":"Department of Biochemistry and Molecular Biology, Brody School of Medicine, East Carolina University;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srikanth","family":"Ravisankar","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Brody School of Medicine at East Carolina University;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230928","doi-asserted-by":"crossref","first-page":"e547","DOI":"10.1542\/peds.2013-3524","article-title":"Neonatal abstinence syndrome","volume":"134","author":"Kocherlakota","year":"2014","journal-title":"Pediatrics."},{"key":"R2-20230928","doi-asserted-by":"crossref","first-page":"e540","DOI":"10.1542\/peds.2011-3212","article-title":"Neonatal drug withdrawal","volume":"129","author":"Hudak","year":"2012","journal-title":"Pediatrics."},{"key":"R3-20230928","doi-asserted-by":"crossref","first-page":"799","DOI":"10.15585\/mmwr.mm6531a2","article-title":"Incidence of neonatal abstinence syndrome\u201428 States, 1999-2013","volume":"65","author":"Ko","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"R4-20230928","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/jp.2015.36","article-title":"Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012","volume":"35","author":"Patrick","year":"2015","journal-title":"J Perinatol."},{"key":"R5-20230928","doi-asserted-by":"crossref","first-page":"e20173520","DOI":"10.1542\/peds.2017-3520","article-title":"Incidence and Costs of neonatal abstinence syndrome among infants with Medicaid: 2004-2014","volume":"141","author":"Winkelman","year":"2018","journal-title":"Pediatrics."},{"key":"R6-20230928","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2012.3951","article-title":"Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009","volume":"307","author":"Patrick","year":"2012","journal-title":"JAMA."},{"key":"R7-20230928","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/add.14192","article-title":"Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway","volume":"113","author":"Nechansk\u00e1","year":"2018","journal-title":"Addiction."},{"key":"R8-20230928","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/imj.13658","article-title":"Adult consequences of prenatal drug exposure","volume":"48","author":"Oei","year":"2018","journal-title":"Intern Med J."},{"key":"R9-20230928","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40352-015-0015-5","article-title":"Pregnant women and substance use: fear, stigma, and barriers to care","volume":"3","author":"Stone","year":"2015","journal-title":"Health Justice."},{"key":"R10-20230928","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.drugpo.2006.09.005","article-title":"Maternal habits: narratives of mothering, social position and drug use","volume":"17","author":"Banwell","year":"2006","journal-title":"Int J Drug Pol."},{"key":"R11-20230928","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/FTD.0b013e31828a6148","article-title":"Alternative matrices for cocaine, heroin, and methadone in utero drug exposure detection","volume":"35","author":"Concheiro","year":"2013","journal-title":"Ther Drug Monit."},{"key":"R12-20230928","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1007\/s00216-007-1228-9","article-title":"Bioanalytical procedures for monitoring in utero drug exposure","volume":"388","author":"Gray","year":"2007","journal-title":"Anal Bioanal Chem."},{"key":"R13-20230928","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/FTD.0b013e31815c14ce","article-title":"Biological matrices for the evaluation of in utero exposure to drugs of abuse","volume":"29","author":"Lozano","year":"2007","journal-title":"Ther Drug Monit."},{"key":"R14-20230928","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/FTD.0000000000000719","article-title":"Testing unconventional matrices to monitor for prenatal exposure to heroin, cocaine, amphetamines, synthetic cathinone, and synthetic opioids","volume":"42","author":"Carlier","year":"2020","journal-title":"Ther Drug Monit."},{"key":"R15-20230928","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/FTD.0000000000000693","article-title":"Monitoring prenatal exposure to buprenorphine and methadone","volume":"42","author":"Di Trana","year":"2020","journal-title":"Ther Drug Monit."},{"key":"R16-20230928","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.forsciint.2005.04.013","article-title":"Assessment of exposure to opiates and cocaine during pregnancy in a Mediterranean city: preliminary results of the \u201cMeconium Project.\u201d","volume":"153","author":"Pichini","year":"2005","journal-title":"Forensic Sci Int."},{"key":"R17-20230928","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0378-4347(97)00479-9","article-title":"Determination of drugs of abuse in meconium","volume":"713","author":"Moore","year":"1998","journal-title":"J Chromatogr B Biomed Sci Appl."},{"key":"R18-20230928","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.clinbiochem.2017.03.006","article-title":"Comparison of umbilical cord tissue and meconium for the confirmation of in utero drug exposure","volume":"50","author":"Colby","year":"2017","journal-title":"Clin Biochem."},{"key":"R19-20230928","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/dta.2087","article-title":"Bioanalysis for cocaine, opiates, methadone, and amphetamines exposure detection during pregnancy","volume":"9","author":"Concheiro","year":"2017","journal-title":"Drug Test Analy."},{"key":"R20-20230928","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/FTD.0b013e3182055f14","article-title":"Nicotine and metabolites in paired umbilical cord tissue and meconium specimens","volume":"33","author":"Marin","year":"2011","journal-title":"Ther Drug Monit."},{"key":"R21-20230928","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/jat\/bkt052","article-title":"Detection of in utero marijuana exposure by GC-MS, ultra-sensitive ELISA and LC-TOF-MS using umbilical cord tissue","volume":"37","author":"Chittamma","year":"2013","journal-title":"J Anal Toxicol."},{"key":"R22-20230928","doi-asserted-by":"crossref","first-page":"587","DOI":"10.4155\/bio-2017-0260","article-title":"Drug exposure during pregnancy: analytical methods and toxicological findings","volume":"10","author":"Concheiro","year":"2018","journal-title":"Bioanalysis."},{"key":"R23-20230928","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12011-016-0853-6","article-title":"Determine multiple elements simultaneously in the sera of umbilical cord blood samples\u2014a very simple method","volume":"177","author":"Liang","year":"2017","journal-title":"Biol Trace Elem Res."},{"key":"R24-20230928","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/jat\/bkx078","article-title":"Development of a liquid chromatography\u2013tandem mass spectrometry method for the simultaneous determination of four cannabinoids in umbilical cord tissue","volume":"42","author":"Wu","year":"2018","journal-title":"J Anal Toxicol."},{"key":"R25-20230928","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/FTD.0000000000000485","article-title":"Detection of drug-exposed newborns","volume":"40","author":"Wabuyele","year":"2018","journal-title":"Ther Drug Monit."},{"key":"R26-20230928","doi-asserted-by":"crossref","first-page":"951616","DOI":"10.1155\/2011\/951616","article-title":"Drug testing for newborn exposure to illicit substances in pregnancy: pitfalls and pearls","volume":"2011","author":"Farst","year":"2011","journal-title":"Int J Pediatr."},{"key":"R27-20230928","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/FTD.0b013e31822724f0","article-title":"Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes","volume":"33","author":"De Castro","year":"2011","journal-title":"Ther Drug Monit."},{"key":"R28-20230928","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.clinbiochem.2017.09.016","article-title":"Method performance and clinical workflow outcomes associated with meconium and umbilical cord toxicology testing","volume":"50","author":"Labardee","year":"2017","journal-title":"Clin Biochem."},{"key":"R29-20230928","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/jat\/bkx097","article-title":"Quantitation of cocaine and metabolites, phencyclidine, butalbital and phenobarbital in meconium by liquid chromatography\u2013tandem mass spectrometry","volume":"42","author":"Scroggin","year":"2018","journal-title":"J Anal Toxicol."},{"key":"R30-20230928","first-page":"16","article-title":"The mass spectrum of cocaine: deuterium labeling and MS\/MS studies","volume":"7","author":"Smith","year":"2010","journal-title":"Microgram J."},{"key":"R31-20230928","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.dmpk.2015.10.002","article-title":"Application of metabolomics to toxicology of drugs of abuse: a mini review of metabolomics approach to acute and chronic toxicity studies","volume":"31","author":"Zaitsu","year":"2016","journal-title":"Drug Metab Pharmacokinet."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0000000000000753","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:23:45Z","timestamp":1785767025000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0000000000000753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000753","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]}}}